We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.
- Authors
Oh, Sung Yong; Kim, Hyun Jin; Kim, Tae Hyo; Lee, Gyeong-Won; Kim, Hoon Gu; Jeong, Chi-Young; Kwon, Hyuk-Chan; Kang, Jung Hun
- Abstract
Gemcitabine- and 5-fluorouracil (5-FU)- based chemotherapy is a commonly used adjuvant or palliative treatment for patients with pancreatic cancer. However, a standard chemotherapy regimen has yet to be developed for patients refractory to gemcitabine and 5-FU treatment. We attempted to evaluate the efficacy and safety of a combination of irinotecan and oxaliplatin (IROX) as a salvage treatment for patients with gemcitabine- and 5-FU- refractory pancreatic cancer.
- Publication
Investigational new drugs, 2010, Vol 28, Issue 3, p343
- ISSN
1573-0646
- Publication type
Journal Article
- DOI
10.1007/s10637-009-9265-1